RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kaliris Salas-Ramirez to Doxorubicin

Back to Details
This is a "connection" page, showing publications Kaliris Salas-Ramirez has written about Doxorubicin.
Kaliris Salas-Ramirez
Connection Strength
0.369
Doxorubicin
  1. Chakrabarti S, Wagh C, Bagnall-Moreau C, Uddin F, Reiser J, Salas-Ramirez K, Ahles T, Hubbard K. Chemotherapy treatment alters DNA methylation patterns in the prefrontal cortex of female rat brain. Sci Rep. 2025 Jul 01; 15(1):20681.
    View in: PubMed
    Score: 0.222
  2. Salas-Ramirez KY, Bagnall C, Frias L, Abdali SA, Ahles TA, Hubbard K. Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways. Behav Brain Res. 2015 Oct 01; 292:133-41.
    View in: PubMed
    Score: 0.111
  3. Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K. Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus. Mol Neurobiol. 2019 Oct; 56(10):7159-7172.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support